One of the privileges of practicing obstetrics and gynecology for decades has been witnessing how reproductive medicine continually evolves. IVF, once considered extraordinary, is now routine. Yet even with all our advances, one question remains central: how can we support healthy pregnancies while minimizing unnecessary medical intervention?
A recent clinical trial suggests we may be able to do exactly that by working more closely with the body’s own hormonal rhythms rather than overriding them.¹
When embryos are transferred during IVF — particularly frozen embryo transfers — the uterine lining must be carefully prepared. Traditionally, many clinics use what is called a programmed cycle, in which estrogen and progesterone are given to control ovulation timing and make scheduling predictable.
There is, however, another option: timing embryo transfer with a woman’s natural ovulation cycle. This approach typically involves less medication but requires more monitoring and flexibility because ovulation timing varies from person to person.¹
Historically, the debate has centered on whether the convenience of programmed cycles comes at any cost to maternal or neonatal outcomes.
A large randomized clinical trial involving nearly 4,400 women undergoing frozen embryo transfer compared these two approaches directly. The findings are reassuring and, in some ways, quite exciting:
- Healthy live birth rates were essentially identical (about 42% natural cycle vs. 41% programmed cycle).¹
- Birth weights and neonatal complications did not differ significantly.¹
- However, pregnancy complications were lower with natural ovulation timing, including:
- Reduced preeclampsia risk
- Lower early pregnancy loss rates
- Fewer placental complications
- Slightly fewer cesarean deliveries and postpartum hemorrhage cases.¹
These findings suggest that allowing the body’s own hormonal environment to guide implantation may offer subtle but meaningful maternal health advantages.
From a physiologic standpoint, ovulation triggers a cascade of endocrine signals affecting the endometrium, immune modulation, vascular adaptation, and placental development. When we override that process entirely with exogenous hormones, we recreate the hormonal environment — but perhaps not perfectly.
This does not mean programmed cycles are harmful or inappropriate. Many patients depend on them due to irregular cycles, logistical constraints, or medical indications. But it does reinforce a broader principle I emphasize often: whenever possible, supporting physiologic processes may improve outcomes.
Despite promising data, natural-cycle frozen embryo transfer is not automatically the best choice for everyone. Some realities include:
- More monitoring visits may be needed.
- Scheduling can be unpredictable.
- Not all patients ovulate reliably.
Clinicians and patients should approach this as another option — not a replacement strategy.
This research aligns with something I often discuss when talking about optimizing fertility naturally: reproductive health reflects overall health. Sleep, stress, nutrition, environmental exposures, metabolic balance — all influence ovulation quality and implantation potential.
When ovulation is strong and consistent, less medical manipulation may be required.
That is not an alternative to assisted reproductive technology; rather, it is a complementary mindset. Supporting the body before and during treatment can potentially improve both pregnancy success and long-term maternal health.
Further trials, including ongoing North American research, will clarify whether these findings translate globally. If confirmed, we may see a gradual shift toward more individualized IVF protocols that respect physiologic cycles whenever feasible.
For patients, this represents empowerment. For clinicians, it represents refinement rather than revolution.
And ultimately, that is how reproductive medicine advances — step by thoughtful step.
- Zi-Jiang Chen et al., “Natural Cycle Versus Programmed Cycle for Frozen Embryo Transfer and Healthy Live Birth: Randomized Clinical Trial,” BMJ, January 2026. Reported in Dennis Thompson, “A ‘Natural’ Option for IVF Is as Effective in Producing Healthy Babies, Trial Shows,” Drugs.com, February 6, 2026.
Dr Marina OBGYN